[Laboratory and clinical studies on clarithromycin in pediatrics].

最大值 克拉霉素 医学 红霉素 流感嗜血杆菌 尿 抗生素 药理学 内科学 药代动力学 微生物学 生物 幽门螺杆菌
作者
Hironobu Akita,Yoshikazu Sato,Satoshi Iwata,Keisuke Sunakawa
出处
期刊:PubMed [National Institutes of Health]
卷期号:42 (2): 264-279 被引量:6
链接
标识
摘要

Clarithromycin (TE-031, A-56268) is a new 14-membered ring macrolide antibiotic developed by Taisho Pharmaceutical Co., Ltd. TE-031 has a methoxy group at position 6 in its structure. In the present study, we carried out laboratory and clinical investigations on TE-031 in the field of pediatrics. The obtained results are summarized as follows. The antibacterial activity of TE-031 was investigated against 16 clinically isolated strains of Streptococcus pyogenes, Staphylococcus aureus, Haemophilus influenzae, Bordetella pertussis and Campylobacter jejuni. TE-031 showed antibacterial activity comparable to erythromycin. The pattern of changes in TE-031 concentrations in the blood after administration was investigated. In subjects administered the granular preparation of TE-031, Cmax values were 0.64 micrograms/ml in 1 subject given a 5 mg/kg dosage, and 5.94 and 9.02 micrograms/ml in 2 subjects administered with 10 mg/kg. The tablet form of TE-031 was administered to 3 subjects at 5 mg/kg, and Cmax values were 2.09-3.92 micrograms/ml, while T 1/2 values were in a range of 2.9-3.8 hours. When drug concentrations in the urine were investigated, it was found that 6-hour recovery rates were 9.9% (dose: 5 mg/kg) and 53.4% (dose: 10 mg/kg) in the subjects administered the granular form, whereas recovery rates averaged 36.8% in the tablet-administered subjects. In the clinical trial, TE-031 was administered in 2-3 doses/day for 2-18 days. In cases given the granular form, dosages were 12-38 mg/kg/day, while tablets were administered at 12-29 mg/kg/day. The overall clinical efficacy rate was 92.8%, i.e., the drug was effective in 64 of 69 patients. TE-031 was ineffective in 1 case of otitis media, but efficacious in 10 of 10 (100%) cases of upper respiratory infection, 15 of 18 (83.3%) cases of bronchitis and pneumonia, 5 of 6 (83.3%) cases of pertussis, 13 of 13 (100%) cases of mycoplasmal pneumonia, 4 of 4 (100%) cases of Chlamydia psittaci pneumonia, 16 of 16 (100%) cases of gastroenteritis (including 15 cases of Campylobacter gastroenteritis), and 1 (100%) case of impetigo. In bacteriological studies conducted on the patients, the overall elimination rate was 93.1%, i.e., bacterial elimination was obtained in 27 of 29 cases. TE-031 showed especially good bacteriological efficacy (100%) against C. jejuni and B. pertussis, which were eliminated from all of 15 and 2 cases examined, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SunnyLife发布了新的文献求助10
刚刚
章文荣完成签到,获得积分10
刚刚
2秒前
LXL发布了新的文献求助10
2秒前
snail完成签到,获得积分10
2秒前
yu完成签到,获得积分10
2秒前
CipherSage的应助被橘色的嘟嘟采纳,获得10
3秒前
3秒前
3秒前
科研小丧彪完成签到,获得积分10
3秒前
仙女的小可爱完成签到 ,获得积分10
3秒前
3秒前
ljx完成签到,获得积分10
4秒前
李刚发布了新的文献求助10
4秒前
remine完成签到,获得积分10
4秒前
香香香发布了新的文献求助10
5秒前
泡泡玛特完成签到 ,获得积分10
5秒前
donkey发布了新的文献求助10
6秒前
7秒前
初景发布了新的文献求助10
7秒前
7秒前
汉堡包的应助被务实一斩采纳,获得10
7秒前
昏睡的帆布鞋完成签到 ,获得积分10
7秒前
学术laji发布了新的文献求助10
7秒前
8秒前
Yeiur发布了新的文献求助10
8秒前
8秒前
8秒前
8秒前
8秒前
昕昕233发布了新的文献求助10
8秒前
龙达绝澈完成签到,获得积分10
9秒前
个性向卉发布了新的文献求助10
10秒前
笨笨小天鹅完成签到,获得积分10
11秒前
冷艳的寒天的应助被YananLi采纳,获得10
11秒前
zzh_zxc完成签到,获得积分10
11秒前
斯文败类的应助被yaya采纳,获得10
11秒前
11秒前
guo完成签到 ,获得积分10
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187612
求助须知:如何正确求助?哪些是违规求助? 9575734
关于积分的说明 21842594
捐赠科研通 7785476
什么是DOI,文献DOI怎么找? 3435073
关于科研通互助平台的介绍 2559478
邀请新用户注册赠送积分活动 2481952